Ganglioside GM3 levels are altered in a mouse model of HIBM: GM3 as a cellular marker of the disease.
<h4>Objective</h4>HIBM (Hereditary Inclusion Body Myopathy) is a recessive hereditary disease characterized by adult-onset, slowly progressive muscle weakness sparing the quadriceps. It is caused by a single missense mutation of each allele of the UDP-N-acetylglucosamine 2-epimerase/N-ac...
Main Authors: | Thomas Paccalet, Zoé Coulombe, Jacques P Tremblay |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-04-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20383336/pdf/?tool=EBI |
Similar Items
-
GM1 and GM2 gangliosides: recent developments
by: Bisel Blaine, et al.
Published: (2014-03-01) -
Ganglioside GM3 Synthase Deficiency in Mouse Models and Human Patients
by: Kei-ichiro Inamori, et al.
Published: (2022-05-01) -
Sialidase NEU3 action on GM1 ganglioside is neuroprotective in GM1 gangliosidosis
by: Maria L. Allende, et al.
Published: (2023-12-01) -
Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review
by: Wenchao Zhang, et al.
Published: (2019-06-01) -
Ganglioside GM3 activates ERKs in human lymphocytic cells
by: Tina Garofalo, et al.
Published: (2002-06-01)